Diagnostic usefulness of the GenoType MTBDRplus assay for detecting drug-resistant tuberculosis using AFB smear-negative specimens with positive TB-PCR result

References

• World Health Organization. Global tuberculosis report 2013. WHO; 2013.
   Google Scholar
• World Health Organization. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. WHO; 2010.
   Google Scholar
• Kim DH, Kim HJ, Park SK, et al. Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis. Am J Respir Crit Care Med. 2010;182:113–119.
   PubMed Web of Science ®Google Scholar
• Shin SS, Keshavjee S, Gelmanova IY, et al. Development of extensively drug-resistant tuberculosis during multidrug-resistant tuberculosis treatment. Am J Respir Crit Care Med. 2010;182:426–432.
   PubMed Web of Science ®Google Scholar
• Nathanson E, Nunn P, Uplekar M, et al. MDR tuberculosis–critical steps for prevention and control. N Engl J Med. 2010;363:1050–1058.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick C, Floyd K. A systematic review of the cost and cost effectiveness of treatment for multidrug-resistant tuberculosis. Pharmacoeconomics. 2012;30:63–80.
   PubMed Web of Science ®Google Scholar
• Pooran A, Pieterson E, Davids M, et al. What is the cost of diagnosis and management of drug resistant tuberculosis in South Africa? PLoS One. 2013;8:e54587.
   PubMed Web of Science ®Google Scholar
• Shah NS, Yuen CM, Heo M, et al. Yield of contact investigations in households of patients with drug-resistant tuberculosis: systematic review and meta-analysis. Clin Infect Dis. 2014;58:381–391.
   PubMed Web of Science ®Google Scholar
• Joh JS, Lee CH, Lee JE, et al. The interval between initiation of anti-tuberculosis treatment in patients with culture-positive pulmonary tuberculosis and receipt of drug-susceptibility test results. J Korean Med Sci. 2007;22:26–29.
   PubMed Web of Science ®Google Scholar
• Koh WJ, Ko Y, Kim CK, et al. Rapid diagnosis of tuberculosis and multidrug resistance using a MGIT 960 system. Ann Lab Med. 2012;32:264–269.
   PubMed Web of Science ®Google Scholar
• Ling DI, Zwerling AA, Pai M. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur Respir J. 2008;32:1165–1174.
   PubMed Web of Science ®Google Scholar
• N’Guessan K, Assi JS, Ouassa T, et al. Assessment of the genotype MTBDRplus assay for rifampin and isoniazid resistance detection on sputum samples in Cote d’Ivoire. Eur J Microbiol Immunol (Bp). 2014;4:166–173.
   PubMedGoogle Scholar
• Aurin TH, Munshi SK, Kamal SM, et al. Molecular approaches for detection of the multi-drug resistant tuberculosis (MDR-TB) in Bangladesh. PLoS One. 2014;9:e99810.
   PubMed Web of Science ®Google Scholar
• Yadav RN, Singh BK, Sharma SK, et al. Comparative evaluation of GenoType MTBDRplus line probe assay with solid culture method in early diagnosis of multidrug resistant tuberculosis (MDR-TB) at a tertiary care centre in India. PLoS One. 2013;8:e72036.
   PubMed Web of Science ®Google Scholar
• Tukvadze N, Kempker RR, Kalandadze I, et al. Use of a molecular diagnostic test in AFB smear positive tuberculosis suspects greatly reduces time to detection of multidrug resistant tuberculosis. PLoS One. 2012;7:e31563.
   PubMed Web of Science ®Google Scholar
• Dorman SE, Chihota VN, Lewis JJ, et al. Genotype MTBDRplus for direct detection of Mycobacterium tuberculosis and drug resistance in strains from gold miners in South Africa. J Clin Microbiol. 2012;50:1189–1194.
   PubMed Web of Science ®Google Scholar
• Huyen MN, Tiemersma EW, Lan NT, et al. Validation of the GenoType MTBDRplus assay for diagnosis of multidrug resistant tuberculosis in South Vietnam. BMC Infect Dis. 2010;10:149.
   PubMed Web of Science ®Google Scholar
• Barnard M, Albert H, Coetzee G, et al. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med. 2008;177:787–792.
   PubMed Web of Science ®Google Scholar
• Jacobson KR, Theron D, Kendall EA, et al. Implementation of genotype MTBDRplus reduces time to multidrug-resistant tuberculosis therapy initiation in South Africa. Clin Infect Dis. 2013;56:503–508.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis-2011 update 2011. WHO; 2011.
   Google Scholar
• Lyu J, Kim MN, Song JW, et al. GenoType(R) MTBDRplus assay detection of drug-resistant tuberculosis in routine practice in Korea. Int J Tuberc Lung Dis. 2013;17:120–124.
   PubMed Web of Science ®Google Scholar
• Ko Y, Lee HY, Lee YS, et al. Esophagomediastinal fistula secondary to multidrug-resistant tuberculous mediastinal lymphadenitis. Intern Med. 2014;53:1819–1824.
   PubMed Web of Science ®Google Scholar
• Ko Y, Lee HY, Lee YS, et al. Multidrug-resistant tuberculosis presenting as miliary tuberculosis without immune suppression: a case diagnosed rapidly with the genotypic line probe assay method. Tuberc Respir Dis (Seoul). 2014;76:245–248.
   PubMedGoogle Scholar
• Park YS, Hong SJ, Boo YK, et al. The national status of tuberculosis using nationwide medical records survey of patients with tuberculosis in Korea. Tuberc Respir Dis (Seoul). 2012;73:48–55.
   PubMedGoogle Scholar
• Bae E, Im JH, Kim SW, et al. [Evaluation of combination of BACTEC mycobacteria growth indicator tube 960 system and Ogawa media for mycobacterial culture.] Korean J Lab Med. 2008;28:299–306 (in Korean).
   PubMedGoogle Scholar
• Lee H, Park KG, Lee G, et al. Assessment of the quantitative ability of AdvanSure TB/NTM real-time PCR in respiratory specimens by comparison with phenotypic methods. Ann Lab Med. 2014;34:51–55.
   PubMed Web of Science ®Google Scholar
• Bai GH, Park YK, Choi YW, et al. Trend of anti-tuberculosis drug resistance in Korea, 1994-2004. Int J Tuberc Lung Dis. 2007;11:571–6.
   PubMed Web of Science ®Google Scholar
• Hain Lifescience GmbH. GenoType MTBDRplus 2.0 product insert. Available from: http://www.hain-lifescience.com
   Google Scholar
• Kang YA, Lee HW, Yoon HI, et al. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA. 2005;293:2756–2761.
   PubMed Web of Science ®Google Scholar
• Gandhi NR, Nunn P, Dheda K, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet. 2010;375: 1830–1843.
   PubMed Web of Science ®Google Scholar
• Orenstein EW, Basu S, Shah NS, et al. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect Dis. 2009;9:153–161.
   PubMed Web of Science ®Google Scholar
• Blumberg HM, Burman WJ, Chaisson RE, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med. 2003;167:603–662.
   PubMed Web of Science ®Google Scholar
• Luetkemeyer AF, Kendall MA, Wu X, et al. Evaluation of two line probe assays for rapid detection of Mycobacterium tuberculosis, tuberculosis (TB) drug resistance, and non-TB Mycobacteria in HIV-infected individuals with suspected TB. J Clin Microbiol. 2014;52:1052–1059.
   PubMed Web of Science ®Google Scholar
• Lacoma A, Garcia-Sierra N, Prat C, et al. GenoType MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples. J Clin Microbiol. 2008;46:3660–3667.
   PubMed Web of Science ®Google Scholar
• Barnard M, Gey van Pittius NC, van Helden PD, et al. The diagnostic performance of the GenoType MTBDRplus version 2 line probe assay is equivalent to that of the Xpert MTB/RIF assay. J Clin Microbiol. 2012;50:3712–3716.
   PubMed Web of Science ®Google Scholar
• Crudu V, Stratan E, Romancenco E, et al. First evaluation of an improved assay for molecular genetic detection of tuberculosis as well as rifampin and isoniazid resistances. J Clin Microbiol. 2012;50:1264–1269.
   PubMed Web of Science ®Google Scholar
• Hirooka T, Higuchi T, Tanaka N, Ogura T. [The value of proper sputum collection instruction in detection of acid-fast bacillus.] Kekkaku. 2004;79:33–7 (in Japanese).
   PubMedGoogle Scholar
• Canadian Tuberculosis Standards, 7th edn. Public Health Agency of Canada, Canadian Lung Association, Canadian Thoracic Society; 2013.
   Google Scholar